bpc-157/tb4 Shop BPC-157 TB4 and TB-500 Peptide Therapy

BPC-157, TB-500, and GHK-Cu reduce inflammatory cytokines while promoting anabolic tissue remodeling, which is the opposite of corticosteroid effects

Laboratory research has documented interactions with vascular endothelial growth factor (VEGF) and related growth factors involved in angiogenesis, the formation of new blood vessels, making this a significant area of interest in regenerative research

Studies by Hsieh and colleagues demonstrated that the peptide promotes VEGFR2 internalization through endocytosis, triggering downstream signaling cascades

This combination brings together two widely studied peptides in regenerative research